Month: September 2025
-
Acer seeking counterleverage against Nokia through “threat letters” in U.S. despite highly asymmetric SEP portfolios and sales volumes: DJ action
Acer sent “threat letters” to U.S. telecommunications carriers using Nokia equipment, provoking a declaratory judgment complaint.
-
Via LA’s automotive Qi licensing glass is half-full as Korean supplier BH EVS joins wireless charging patent pool
Via LA’s Qi patent pool has now licensed approximately 50% of the global automotive supplier market.
-
Oura escalates Ultrahuman patent dispute with more patents and accusations of editing Wikipedia page to accuse Oura of patent trolling
The patent dispute between smart-ring pioneer Oura and Ultrahuman is getting dirty, with Oura accusing Ultrahuman of having edited its Wikipedia page and impersonated its CEO.
-
Stanford retains cancer detection patents licensed to Foresight Diagnostics, but Roche gets non-exclusive license: settlement
Roche Molecular Systems, Stanford and Foresight Diagnostics have recently settled a dispute over trade secrets, breach of contract, unfair competition and patent ownership.
-
Post-judgment cleanup orders in UK pharma cases: no disgorgement of Bayer profits; Teva, Glenmark, Generics (UK) recover two thirds of costs
AstraZeneca must reimburse two thirds of the costs of an unsuccessful case Teva, Glenmark and Generics (UK). Separately, Bayer does not have to disgorge profits to Sandoz.
-
Judge dismisses Ultrahuman’s Indian countersuit against Oura for failure to disclose key information from ITC case: Ultrahuman must refile
Mrs. Justice Arora faults Ultrahuman for not disclosing ITC decisions that were relevant to the question of whether Ultrahuman’s Indian patent-in-suit is valid.